Compare VICI & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VICI | RMD |
|---|---|---|
| Founded | 2016 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 36.4B |
| IPO Year | N/A | 1995 |
| Metric | VICI | RMD |
|---|---|---|
| Price | $28.15 | $251.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $34.67 | ★ $289.09 |
| AVG Volume (30 Days) | ★ 13.8M | 922.1K |
| Earning Date | 02-19-2026 | 01-29-2026 |
| Dividend Yield | ★ 6.53% | 0.97% |
| EPS Growth | N/A | ★ 29.59 |
| EPS | 2.63 | ★ 9.77 |
| Revenue | $3,969,078,000.00 | ★ $5,257,400,000.00 |
| Revenue This Year | $5.66 | $9.85 |
| Revenue Next Year | $2.85 | $7.36 |
| P/E Ratio | ★ $10.48 | $25.40 |
| Revenue Growth | 4.31 | ★ 9.36 |
| 52 Week Low | $27.55 | $199.92 |
| 52 Week High | $34.03 | $293.81 |
| Indicator | VICI | RMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 55.41 |
| Support Level | $27.56 | $240.00 |
| Resistance Level | $28.45 | $250.15 |
| Average True Range (ATR) | 0.39 | 4.02 |
| MACD | 0.06 | 0.89 |
| Stochastic Oscillator | 66.50 | 99.10 |
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.